Skip to content

Investigator

Sanjay K Jain

CINCINNATI CHILDRENS HOSP MED CTR · funded by NIAID

Companies
1

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$5.3M

Summed across those awards.

First award
Feb 24, 2025

Latest Aug 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Animal Models to Develop New Regimens for S. aureus Implant-Associated Infections

    $3.3M

    Aug 1, 2025NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11446824 (opens the source filing in a new tab)

  2. R21

    PET to Assess Post-TB Lung Disease in TB Patients with / without HIV coinfection

    $446k

    Jul 1, 2025NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11445100 (opens the source filing in a new tab)

  3. R01

    Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis

    $775k

    Feb 24, 2025NIAIDJOHNS HOPKINS UNIVERSITYNIH RePORTER · 11101929 (opens the source filing in a new tab)

  4. R01

    Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis”

    $810k

    Feb 24, 2025NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11452554 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources